XM does not provide services to residents of the United States of America.
A
A

AutomaticData

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. CH Robinson Worldwide, Dayforce, Entegris

U.S. RESEARCH ROUNDUP-CH Robinson Worldwide, Dayforce, Entegris Aug 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CH Robinson Worldwide, Dayforce and Entegris, on Thursday. HIGHLIGHTS * CH Robinson Worldwide Inc CHRW.O : JP Morgan raises to overweight from neutral * Dayforce Inc DAY.N : Piper Sandler raises to overweight from neutral * Entegris Inc ENTG.O : Seaport Research Partners raises to buy from neutral * M
B
C
D
E
M
Q
S
V
A
C
D
E
L
T
P
W
A
B
C

Dayforce lifts annual revenue forecast on strong payroll demand; shares rise

Dayforce lifts annual revenue forecast on strong payroll demand; shares rise July 31 (Reuters) - Dayforce DAY.N raised its full-year revenue forecast on Wednesday, banking on robust demand for its payroll and human capital management services, sending its shares up 8% in premarket trading. Strong client spending on the company's flagship Dayforce platform that provides services such as cloud-based human resource management, recruiting and payroll processing boosted its second-quarter recurring r
A

ADP beats fourth-quarter revenue estimates on steady payroll demand

ADP beats fourth-quarter revenue estimates on steady payroll demand July 31 (Reuters) - Automatic Data Processing ADP.O beat Wall Street expectations for fourth-quarter revenue on Wednesday, helped by robust demand for its human resource management and payroll services. Employee management services by ADP, one of the biggest payroll processing companies in the world, have been seeing consistent demand even as the labor market cooled from its high growth levels seen at the start of the year.
A
P
A

ADP Q4 Adjusted EPS USD 2.09 Vs. IBES Estimate USD 2.06

BRIEF-ADP Q4 Adjusted EPS USD 2.09 Vs. IBES Estimate USD 2.06 Jul 31 (Reuters) - ADP Q4 adjusted EBIT USD 1,100 million vs. IBES estimate USD 1,125 million. Q4 adjusted EBIT margin 23.3% Q4 EPS USD 2.02
A

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5)

CORRECTED-U.S. RESEARCH ROUNDUP-Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5) Corrects U.S. research roundup dated Aug. 5 to remove dated research actions from headline and tables, the errors appeared in previous versions also Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday.
A
A
B
I
M
P
A
A
E
A
E
I
A
A
A
A
F
G
H
L
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.